XML 45 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2023
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Dr. Kristian Reich [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On October 16, 2023, Dr. Kristian Reich, the Chief Scientific Officer of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c). Dr. Reich’s plan provides for the sale, subject to certain conditions, of up to 200,000 Class A Ordinary Shares held directly and indirectly by Dr. Reich. The plan terminated on February 28, 2024.
Name Dr. Kristian Reich  
Title Chief Scientific Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 16, 2023  
Arrangement Duration 135 days  
Aggregate Available 200,000 200,000
Dr. Jorge Santos da Silva [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
On October 17, 2023, Dr. Jorge Santos da Silva, the Chief Executive Officer and a director of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c). Dr. Santos da Silva’s plan provides for the sale of up to 200,000 Class A Ordinary Shares, subject to certain conditions. The plan terminated on February 29, 2024.
Name Dr. Jorge Santos da Silva  
Title Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date October 17, 2023  
Arrangement Duration 135 days  
Aggregate Available 200,000 200,000